Carcinoma ex-pleomorphic adenoma (Ca-ex-PA) is a malignant tumor developing in a pre-existing or concurrent pleomorphic adenoma and constitutes 5-15% of all salivary gland malignancies. Risk of malignant transformation is directly proportional to tumor duration: <2% for less than 5 years, up to 10-25% for more than 15 years. Histologically, pre-existing pleomorphic adenoma remnant (usually T2 hyperintense myxoid/chondroid matrix) and new malignant component (usually adenocarcinoma NOS, myoepithelial carcinoma, or undifferentiated carcinoma) coexist — 'tumor within tumor' appearance. Clinically, the classic triad is sudden size increase, pain onset, and facial nerve paralysis development in a long-standing painless parotid mass. Classified into three categories by invasion depth: intracapsular (non-invasive, excellent prognosis), minimally invasive (≤1.5 mm capsule penetration, good prognosis), and invasive (extensive beyond-capsule invasion, poor prognosis, >50% 5-year mortality). On imaging, the coexistence of old benign component (well-defined, T2 hyperintense, slowly enhancing) and new malignant component (irregular margins, diffusion-restricting, heterogeneously enhancing) is diagnostic.
Age Range
50-80
Peak Age
65
Gender
Equal
Prevalence
Rare
The pathophysiological basis of imaging findings in Ca-ex-PA lies in the striking contrast differences resulting from the coexistence of benign and malignant components. The original pleomorphic adenoma is a T2-hyperintense area that does not show diffusion restriction (high ADC) due to the high water content of myxoid/chondroid matrix. Malignant transformation typically begins in cellular areas near the capsule — high nuclear/cytoplasmic ratio, increased mitotic activity, and stromal invasion develop. The malignant component shows diffusion restriction due to high cellularity (low ADC, typically <1.0 × 10⁻³ mm²/s) and shows lower T2 signal than the benign component. Neovascularization creates early and heterogeneous enhancement. Capsule disruption signals the invasive form — irregular margins and extension into surrounding structures (facial nerve, parotid parenchyma, skin) are seen. Intratumoral necrosis, hemorrhage, and calcifications increase tumor heterogeneity. Facial nerve paralysis results from perineural invasion of the malignant component. Metastatic lymph nodes show low ADC and irregular enhancement.
Coexistence of old pleomorphic adenoma remnant (hyperintense myxoid area) and new malignant component (lower signal, irregular margins) within on T2-weighted MRI — diagnostic finding for Ca-ex-PA.
The most diagnostic finding of Ca-ex-PA on ADC maps is the dual-component ADC pattern: old pleomorphic adenoma remnant shows high ADC (>1.5 × 10⁻³ mm²/s, myxoid matrix) while the new malignant component shows low ADC (<1.0 × 10⁻³ mm²/s, high cellularity). The ADC difference between these two components is the most valuable diagnostic criterion and helps differentiate from de novo malignant tumors.
Report Sentence
A dual-component pattern is identified within the lesion on ADC map: coexistence of old component showing high ADC and new aggressive component showing low ADC is consistent with carcinoma ex-pleomorphic adenoma.
T2-weighted MRI shows heterogeneous signal: old pleomorphic adenoma remnant is markedly T2 hyperintense (myxoid matrix), new malignant component shows lower T2 signal (cellular tissue). This dual signal pattern creates the 'tumor within tumor' appearance and is diagnostic for Ca-ex-PA.
Report Sentence
The lesion demonstrates heterogeneous signal on T2-weighted sequences, with coexistence of hyperintense old component and low-signal new component creating a 'tumor within tumor' appearance.
Contrast-enhanced CT shows a heterogeneously enhancing mass. Old benign component shows low-moderate enhancement while new malignant component enhances prominently. In invasive form, capsule disruption, irregular margins, and extension into surrounding structures are seen. Calcifications may be seen in the old component. Necrotic areas remain hypodense.
Report Sentence
A heterogeneously enhancing mass is identified in the parotid gland with irregular margins and capsule disruption; malignant transformation (carcinoma ex-pleomorphic adenoma) should be primarily considered.
US shows a heterogeneous, mixed echogenic mass. Old benign component is a regular-bordered, hypoechoic area while new malignant component appears more hypoechoic, irregular-bordered, and solid. Capsule disruption may be detected.
Report Sentence
A mixed echogenic, heterogeneous mass is identified in the parotid gland with coexistence of irregular-bordered new solid component and old hypoechoic component.
Heterogeneous enhancement pattern on post-contrast T1 sequences. Malignant component enhances early and prominently while old benign component enhances late and mildly or shows no enhancement. This enhancement difference reflects the vascularity difference between two components.
Report Sentence
On post-contrast series, the lesion demonstrates heterogeneous enhancement, with early and prominently enhancing malignant component distinguished from late/minimally enhancing benign component.
Calcifications may be detected in the old pleomorphic adenoma component on non-contrast CT (10-20%). Calcifications may be dystrophic or flocculent in pattern and are a finding supporting a long-standing tumor. Presence of calcification indicates that the malignant transformation process has a long chronological history. The new malignant component generally does not contain calcification — appears as a solid mass of soft tissue density. The contrast between calcified old component and non-calcified new aggressive component is the CT equivalent of the 'tumor within tumor' pattern.
Report Sentence
Calcifications are identified within the old component of the lesion, supporting a long-standing pre-existing pleomorphic adenoma.
Criteria
Malignant component confined within capsule
Distinct Features
Intact capsule, well-defined mass, excellent prognosis
Criteria
Capsule penetration ≤1.5 mm
Distinct Features
Focal capsule disruption, limited surrounding invasion
Criteria
Extensive beyond-capsule invasion
Distinct Features
Irregular margins, invasion of surrounding structures, facial nerve involvement, poor prognosis
Distinguishing Feature
Homogeneous T2 hyperintensity in pleomorphic adenoma, no diffusion restriction, well-defined intact capsule
Distinguishing Feature
No 'tumor within tumor' pattern in de novo mucoepidermoid — homogeneous malignant mass
Distinguishing Feature
Perineural spread is prominent in adenoid cystic carcinoma and there is no old benign component
Urgency
urgentManagement
surgicalBiopsy
NeededFollow-up
specialist-referralRadical surgical resection + adjuvant radiotherapy is standard treatment. Radical parotidectomy may be required if facial nerve is involved. Prognosis depends on invasion depth: intracapsular 100% survival, invasive form >50% 5-year mortality. Distant metastasis (lung most common) may develop.
Requires radical surgery + adjuvant radiotherapy. Prognosis depends on depth of invasion (intracapsular: good; extracapsular: poor). Facial nerve preservation should be planned.